Medical and scientific conferences are the hub of biopharmaceutical activity. They are the intersection points for company announcements, industry dialogue, and interaction with KOLs, making them important sources of primary and secondary competitive intelligence.
C5i helps companies gain meaningful competitive and market insights from conferences through comprehensive pre-conference planning, effective intelligence gathering during the conference, and insightful post-conference reports.
Get contextual insights on key updates, pipeline developments, and emerging thinking on key therapeutic interventions. Find out what your competitors and decision-makers are thinking. Guide your market strategy with insights.
Provide end-to-end conference coverage including primary and secondary intelligence gathering based on KITs and KIQs
To provide CI support through continuous monitoring and reporting of key competitor events in biosimilars